Post-Conference Report
This report offers a guide to the immune-related abstracts presented at the 2024 annual meeting. It includes an analysis of abstract distribution by type, therapeutic class, disease, and phase. Additionally, the report features individual summaries categorized by clinical trial, trial outline and preclinical trials, each with direct links to their corresponding drugs in the Beacon database.
We believe this report will be an invaluable and insightful resource for exploring the latest advancements in Immune Tolerance.
Beacon Immune Tolerance
How the most complete immune tolerance database can help you
What we cover
Beacon Immune Tolerance covers all pharmaceutical interventions used to treat autoimmune diseases, autoinflammatory diseases, alloimmune diseases and allergies.
From small molecules to CAR T therapy, the module encapsulates all drugs and therapies within the immune-mediated disease space.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the immune tolerance space
New data expansion: Deals and Companies. Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more about Deals and Companies data by downloading the factsheet.
How Beacon Immune Tolerance works
All Immune Tolerance pages will have unique data fields that will help speed up the research process. These data fields include:
- Autoantigen specificity
- Mechanism of Action
- Cell Source
- Cell Type
- Delivery System
- Editing Technology
- Target Organ/Cell
- Formulation
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.
